A randomized phase II study of stem cell mobilization with cyclophosphamide+G-CSF or G-CSF alone after lenalidomide-based induction in multiple myeloma
Silvennoinen, R, Anttila, P, Säily, M, Lundan, T, Heiskanen, J, Siitonen, T M, Kakko, S, Putkonen, M, Ollikainen, H, Terävä, V, Kutila, A, Launonen, K, Räsänen, A, Sikiö, A, Suominen, M, Bazia, P, Kananen, K, Selander, T, Kuittinen, T, Remes, K, Jantunen, E
Published in Bone marrow transplantation (Basingstoke) (01.03.2016)
Published in Bone marrow transplantation (Basingstoke) (01.03.2016)
Get full text
Journal Article
Carfilzomib, Elotuzumab and Dexamethasone for Relapsed or Refractory Myeloma Patients
Silvennoinen, Raija Helena, Nahi, Hareth, Anttila, Pekka, Koskenvesa, Perttu, Lievonen, Juha, Marttila, Anu, Varmavuo, Ville, Sikiö, Anu, Nurmi, Marita, Säily, Marjaana, Partanen, Anu, Sankelo, Marja, Luoma, Sini, Mäntymaa, Pentti, Ilveskero, Sorella, Rode Eshoj, Henrik, Nielsen, Lene Kongsgaard, Jantunen, Esa, Heckman, Caroline A
Published in BLOOD (05.11.2020)
Published in BLOOD (05.11.2020)
Get full text
Journal Article
Conference Proceeding
A Prospective Phase 2 Study to Assess Minimal Residual Disease after Ixazomib, Lenalidomide and Dexamethasone Treatment for Newly Diagnosed Transplant Eligible Multiple Myeloma Patients
Silvennoinen, Raija Helena, Waage, Anders, Peceliunas, Valdas, Schjesvold, Fredrik, Anttila, Pekka, Säily, Marjaana, Putkonen, Mervi, Carlson, Kristina, Haukaas, Einar, Sankelo, Marja, Partanen, Anu, Szatkowski, Damian L., Hansson, Markus, Marttila, Anu, Ahlberg, Lucia, Axelsson, Per, Lauri, Birgitta, Mikkola, Maija Helena, Karlsson, Conny, Abelsson, Johanna, Ahlstrand, Erik, Sikiö, Anu, Klimkowska, Monika, Matuzeviciene, Reda, Hoysaeter Fenstad, Mona, Ilveskero, Sorella, Nahi, Hareth
Published in BLOOD (05.11.2020)
Published in BLOOD (05.11.2020)
Get full text
Journal Article
Conference Proceeding
A randomized phase II study of stem cell mobilization with cyclophosphamide + G-CSF versus G-CSF alone after lenalidomide-based induction in multiple myeloma
Silvennoinen, R, Anttila, P, Säily, M, Lundan, T, Heiskanen, J, Siitonen, T.M, Kakko, S, Putkonen, M, Ollikainen, H, Terävä, V, Kutila, A, Launonen, K, Räsänen, A, Sikiö, A, Suominen, M, Bazia, P, Kananen, K, Selander, T, Kuittinen, T, Remes, K, Jantunen, E
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Get full text
Journal Article
A prospective phase 2 study to assess minimal residual disease after ixazomib plus lenalidomide plus dexamethasone (IRd) treatment for newly diagnosed transplant eligible multiple myeloma patients
Silvennoinen, R, Waage, A, Peceliunas, V, Schjesvold, F, Anttila, P, Uttervall, K, Saily, M, Putkonen, M, Carlson, K, Haukas, E, Sankelo, M, Partanen, A, Szatkowski, D, Hansson, M, Marttila, A, Svensson, R, Axelsson, P, Lauri, B, Mikkola, M, Karlsson, C, Abelsson, J, Ahlstrand, E, Sikio, A, Nahi, H
Published in CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2022)
Get full text
Published in CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2022)
Conference Proceeding
A phase 2 study of carfilzomib plus elotuzumab plus dexamethasone for myeloma patients relapsed after 1-3 prior treatment lines
Silvennoinen, Raija, Majumder, Muntasir Mamun, Tsallos, Dimitrios, Nahi, Hareth, Anttila, Pekka, Partanen, Anu, Luoma, Sini, Sikiö, Anu, Nurmi, Marita, Varmavuo, Ville, Säily, Marjaana, Sankelo, Marja, Jantunen, Esa, Pelliniemi, Tarja-Terttu, Ilveskero, Sorella, Eshoj, Henrik Rode, Nielsen, Lene Kongsgaard, Eldfors, Samuli, Leppä, Aino-Maija, Heckman, Caroline
Published in CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (01.10.2019)
Published in CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (01.10.2019)
Get full text
Journal Article
Conference Proceeding
IgA nephropathy in a patient with IgG lambda light-chain plasmacytoma: a rare coincidence
Forslund, Terje, Sikiö, Anu, Anttinen, Jorma
Published in Nephrology, dialysis, transplantation (01.09.2007)
Published in Nephrology, dialysis, transplantation (01.09.2007)
Get full text
Journal Article
Ixazomib, Lenalidomide, and Dexamethasone (IRD) Treatment with Cytogenetic Risk-Based Maintenance in Transplant-Eligible Myeloma: A Phase 2 Multicenter Study by the Nordic Myeloma Study Group
Partanen, Anu, Waage, Anders, Peceliunas, Valdas, Schjesvold, Fredrik, Anttila, Pekka, Säily, Marjaana, Uttervall, Katarina, Putkonen, Mervi, Carlson, Kristina, Haukas, Einar, Sankelo, Marja, Szatkowski, Damian, Hansson, Markus, Marttila, Anu, Svensson, Ronald, Axelsson, Per, Lauri, Birgitta, Mikkola, Maija, Karlsson, Conny, Abelsson, Johanna, Ahlstrand, Erik, Sikiö, Anu, Klimkowska, Monika, Matuzeviciene, Reda, Fenstad, Mona Hoysaeter, Ilveskero, Sorella, Pelliniemi, Tarja-Terttu, Nahi, Hareth, Silvennoinen, Raija
Published in Cancers (2024)
Published in Cancers (2024)
Get full text
Journal Article